Newly prequalified Active Pharmaceutical Ingredient (API)
M
Molnupiravir (WHOAPI-449) manufactured by Shanghai Desano Chemical Pharmac
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Molnupiravir (WHOAPI-438) manufactured by Optimus Drugs Pvt Ltd, has been
Huayi’s sulfamethoxazole/trimethoprim tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequa
WHO Prequalification Team - Medicines (PQT/MED) has issued new guidance on the recommended style to be used for visual description of oral dosage forms in WHO Public Assessment Reports (WHOPARs)
M
WHO Prequalification Team - Medicines (PQT/MED) has issued a new guidance on the recommended style to be used for visual description of oral dosage forms in WHO Public Assessment Reports
Beijing Holley-Cotec’s DHA/piperaquine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Celltrion’s nirmatrelvir + ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: